213 related articles for article (PubMed ID: 14659136)
1. Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer.
Senn HJ; Thürlimann B; Goldhirsch A; Wood WC; Gelber RD; Coates AS
Breast; 2003 Dec; 12(6):569-82. PubMed ID: 14659136
[TBL] [Abstract][Full Text] [Related]
2. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.
Goldhirsch A; Wood WC; Gelber RD; Coates AS; Thürlimann B; Senn HJ
J Clin Oncol; 2003 Sep; 21(17):3357-65. PubMed ID: 12847142
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations.
Carlson RW; Hudis CA; Pritchard KI; ; ;
J Natl Compr Canc Netw; 2006 Nov; 4(10):971-9. PubMed ID: 17112447
[TBL] [Abstract][Full Text] [Related]
4. [Trend to adjuvant systemic treatment regimens for patients with early breast cancer--meeting highlights of St. Gallen Conference 2005].
Taguchi T
Gan To Kagaku Ryoho; 2006 May; 33(5):567-83. PubMed ID: 16685151
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
Kahlert S; von Koch F; Ditsch N; Untch M
Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):102-12. PubMed ID: 15073439
[TBL] [Abstract][Full Text] [Related]
6. [Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)].
Thürlimann B; Senn HJ
Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):143-6. PubMed ID: 15990439
[TBL] [Abstract][Full Text] [Related]
7. St. Gallen endocrine response classes predict recurrence rates over time.
Koornstra RH; Beelen KJ; Vincent AD; van der Noort V; van Diest PJ; Linn SC
Breast; 2015 Dec; 24(6):705-12. PubMed ID: 26429398
[TBL] [Abstract][Full Text] [Related]
8. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.
Michaud LB; Buzdar AU
Drugs Aging; 2000 Apr; 16(4):261-71. PubMed ID: 10874521
[TBL] [Abstract][Full Text] [Related]
9. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
Carlson RW; Henderson IC
Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
[TBL] [Abstract][Full Text] [Related]
10. Endocrine therapy for early breast cancer.
Hussain SA; Williams S; Stevens A; Rea DW
Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
[TBL] [Abstract][Full Text] [Related]
11. Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age.
Verma S; Jackisch C
Expert Rev Anticancer Ther; 2011 Feb; 11(2):277-86. PubMed ID: 21342045
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant chemotherapy in primary carcinoma of the breast].
Harbeck N
Zentralbl Gynakol; 2003 Sep; 125(9):322-6. PubMed ID: 14569511
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM).
Gori S; Puglisi F; Cinquini M; Pappagallo G; Frassoldati A; Biganzoli L; Cortesi L; Fiorentino A; Angiolini C; Tinterri C; De Censi A; Levaggi A; Del Mastro L
Eur J Cancer; 2018 Aug; 99():9-19. PubMed ID: 29886394
[TBL] [Abstract][Full Text] [Related]
14. Meeting highlights--International Consensus Panel on the treatment of primary breast cancer.
Taguchi T
Gan To Kagaku Ryoho; 2002 Mar; 29(3):347-63. PubMed ID: 11915723
[TBL] [Abstract][Full Text] [Related]
15. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
Buzdar A; Chlebowski R; Cuzick J; Duffy S; Forbes J; Jonat W; Ravdin P
Curr Med Res Opin; 2006 Aug; 22(8):1575-85. PubMed ID: 16870082
[TBL] [Abstract][Full Text] [Related]
16. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.
Goldhirsch A; Wood WC; Gelber RD; Coates AS; Thürlimann B; Senn HJ;
Ann Oncol; 2007 Jul; 18(7):1133-44. PubMed ID: 17675394
[TBL] [Abstract][Full Text] [Related]
17. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
Goldhirsch A
Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
Come SE; Buzdar AU; Ingle JN; Johnston SRD; Brodie AM; Coombes RC; Miller WR; Pritchard KI; Winer EP; Zujewski JA; Goss PE
Cancer; 2008 Feb; 112(3 Suppl):673-678. PubMed ID: 18072254
[TBL] [Abstract][Full Text] [Related]
19. Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.
Colleoni M; Munzone E
Drugs; 2015 Aug; 75(12):1311-21. PubMed ID: 26177891
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer update.
Kuter I
Oncologist; 2000; 5(4):285-92. PubMed ID: 10964995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
